WIINBERG ULF - Insider Non-Derivative Transactions at MiNK Therapeutics, Inc. (INKT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 1, 2025, WIINBERG ULF's relationship to MiNK Therapeutics, Inc. (INKT) is Director, and currently has 20,234 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other INKT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

WIINBERG ULF - Insider Non-Derivative Transactions of INKT Common Stock

WIINBERG ULF - Insider Non-Derivative Transactions at INKT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 2, 2025	Acquisition -- (Common Stock)	1263	11.09	20234
Sep 3, 2025	Acquisition -- (Common Stock)	1011	13.86	18971
Jun 3, 2025	Acquisition -- (Common Stock)	1953	7.17	17960
Mar 4, 2025	Acquisition -- (Common Stock)	1593	8.79	16007
Dec 2, 2024	Acquisition -- (Common Stock)	20476	0.73	144181
Sep 4, 2024	Acquisition -- (Common Stock)	18295	0.82	123705
Jun 4, 2024	Acquisition -- (Common Stock)	15077	0.99	105410
Mar 2, 2024	Acquisition -- (Common Stock)	15790	0.95	90333
Dec 2, 2023	Acquisition -- (Common Stock)	14424	1.04	74543
Sep 2, 2023	Acquisition -- (Common Stock)	9590	1.46	60119
Jun 2, 2023	Acquisition -- (Common Stock)	7955	1.76	50706
Mar 2, 2023	Acquisition -- (Common Stock)	6699	2.09	42751